12:00 AM
Jun 18, 2012
 |  BC Week In Review  |  Company News  |  Deals

Amorfix, JSW Lifesciences GmbH deal

CRO JSW Lifesciences received an exclusive, worldwide license to market and to use as a service Amorfix's Amorfix Aggregated Abeta Assay (A4) for preclinical...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >